We’re Just
Getting Started

A 10-Year Plan to Beat Inflammation

Over the next decade we will use our combined resources, infrastructure, and experience to accelerate our drug discovery efforts, investigating potential new therapies for rheumatoid arthritis, IBD, and many other inflammatory illnesses.

scroll

Our 10-Year Plan

Utilise our unique discovery engine

To find and deliver advanced new therapies

With a combined infrastructure that helps deliver to patients

While accelerating development of further advanced therapies

WE’RE FOCUSED ON ADVANCED
TREATMENTS FOR THE FUTURE.

Gilead and Galapagos are committed to advancing the treatment of inflammatory diseases and improving patient lives through our partnerships and collaborations with the scientific and medical community. We are studying multiple molecules for the treatment of IBD, with several clinical trials in both ulcerative colitis and Crohn’s disease.

Adapted from: 1. www.gilead.com/science-and-medicine/pipeline. Accessed August, 2020. 2. www.clinicaltrials.gov. Accessed August, 2020.

Click here to view progress